BioSpace News Archive

The EPA-approved protocol can be used to evaluate the effectiveness of treatments in reducing microbial contamination in agricultural water

iBIO, the Illinois Biotechnology Innovation Organization, announced the launch of Transform Illinois, http://ibio.org, its innovative new program to enhance pandemic preparedness and recovery, erase health equity barriers and continue to nurture the state’s life sciences community.

SIGA Technologies, Inc., a commercial-stage pharmaceutical company focused on the health security market, announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Thursday, August 6, 2020.

HTG Molecular Diagnostics, Inc., a life science company whose mission is to advance precision medicine, announced three of its previously released Research Use Only assays are now available for use with the Thermo Fisher Scientific Ion Torrent Ion S5 next-generation sequencing platform.

Optinose, a pharmaceutical company focused on patients treated by ear, nose and throat and allergy specialists, announced the Company will report financial results for the second quarter 2020 and corporate updates, before market open on Tuesday, August 4, 2020.

PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company’s proprietary Versamune ® T-cell activating technology, today announced that the Company will report financial results for the second quarter ended June 30, 2020 on Thursday, August 13, 2020, before the market opens. Following the release, Dr. Frank Bedu-Addo, Chief Exec

Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced the appointment of Martin W. Edwards, M.D. to its Board of Directors, effective August 3, 2020.

Q2-2020 Key Results Revenue (millions) $ 84.8 • Newborn Care revenue increased 1% compared to second quarter last year • Reduced debt by $13.0 million during the quarter • NICVIEW II released during the quarter GAAP loss per share $ 0.26 Non-GAAP loss per share $ 0.13

Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, will report second quarter 2020 financial results on Thursday, August 6, 2020, after the U.S. financial markets close. Dynavax will host a conference call and live audio webcast on Thursday, August 6, 2020 at 4:30 p.m. (ET)/1:30 p.m. (PT). The live audio webcast may be accessed through the “Events &am

BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the quarter ended June 30, 2020. Company Highlights Recognized quarterly total revenue of $99.1 million Total revenue declined 11.4% year-over-year due to the impact of COVID-19 across most of our businesses Reported quarterly GAAP net i